Lasa Supergenerics Ltd receives further Injunction from Hon'ble High Court, Bombay restraining its competitor from Manufacturing albendazole

Lasa Supergenerics Limited (Lasa), India's leading API manufacturer, announced that it has been granted Injunction order against its competitor from Hon'ble High Court, Bombay vide order dated 23rd November 2020.

Commenting on this development, Dr. Omkar Herlekar, Chairman & Managing Director, Lasa Supergenerics said: It is one of the biggest achievements in the history of Lasa, Our Legal Team and Counsels made it possible to achieve this even in this difficult times.

The receipt of this relief is the milestones for Lasa, as it will restrain its competitor to manufacture and deal in one of the key product and enables the company to continue its leadership for its key products worldwide. We are keeping a close watch in the market in respect of illegal activities of some traders and we are ready to initiate civil and/or criminal actions to protect our invention and proprietary information.

Reliefs as granted by Hon'ble High Court, Bombay which shall continue till the disposal of the suits are as follows:

"(a) pending the hearing and final disposal of the present suit the respondents by itself or through its directors, group companies, associates, divisions, assigns in business, servants, job workers, proprietors, partners, licensees, franchisees, agents, distributors, dealers, stockists and all persons claiming through the respondents directly or indirectly be restrained by a temporary order and injunction of this Hon'ble Court from adopting/using the applicant's patented process which is the subject matter of Patent No.326628 or from manufacturing Albendazole i.e. Methyl 5-(propylthio)-lhbenzo (d) imidazol-2-ylcarbamate by use of the patented process which is the subject matter of Patent No.326628 or from adopting, using, sellng, offering for sale, importing, exporting or dealing in Albendazole i.e. Methyl 5 -(propylthio)-lh-benzo (d) imidazol-2-ylcarbamate manufactured by use of the patented process which is the subject matter of Patent No.326628 of the applicant or any other process as may be substantially similar thereto amounting to infringement of Indian Patent No.326628 of the applicant.

"(b) Pending the hearing and final disposal of the present suit the Respondent Nos. 1 and 2, by itself or through its directors, group companies, associates, divisions, assigns in business, servants, job workers, proprietors, partners, licensees, franchisees, agents, distributors, dealers, stockists and all persons claiming through the Respondents, directly or indirectly, be restrained by a temporary order and injunction of this Hon'ble Court from selling, offering for sale, importing, exporting or dealing in Albendazole i.e. Methyl 5-(propylthio)-lh-benzo [d] imidazol-2-ylcarbamate manufactured by use of the Confidential Information, details and particulars of which are given in Paragraph 31 of the plaint;

(c) Pending the hearing and final disposal of the present suit the Respondent Nos. 1 and 2, by itself or through its directors, group companies, associates, divisions, assigns in business, servants, job workers, proprietors, partners, licensees, franchisees, agents, distributors, dealers, stockists and all persons claiming through the Respondents, directly or indirectly, be restrained by a temporary order and injunction of this Hon'ble Court from using, making copies of, disclosing / divulging / parting with possession / distributing / circulating to any third parties by any means, mode or method, directly or indirectly, in any manner, the said Confidential Information, details and particulars of which are given in Paragraph 31 of the plaint;

Lasa has subsisting process patent in its name for the invention titled "AN IMPROVED PROCESS FOR THE PREPARATION OF METHYL 5- (PROPYLTHIO)-1H-BENZO [D] IMIDAZOL-2-YLCARBAMATE" and it's products based on the patented process and by use of its confidential information comprised over 85% of the company's FY2020 revenues.

Shares of Lasa Supergenerics Ltd was last trading in BSE at Rs.81.75 as compared to the previous close of Rs. 77. The total number of shares traded during the day was 39376 in over 976 trades.

The stock hit an intraday high of Rs. 84 and intraday low of 75. The net turnover during the day was Rs. 3153308.

Source : Equity Bulls

Keywords